Key result
Blood transfusions following aortic valve replacement are associated with adverse outcomes, highlighting the need for judicious use to minimize patient harm and ensure efficient resource allocation.
Why the study?
What are the implications and adverse outcomes associated with blood transfusion after surgical and transcatheter aortic valve replacement?
What are the implications and adverse outcomes associated with blood transfusion after surgical and transcatheter aortic valve replacement?
Blood transfusions after aortic valve replacement are associated with significant adverse outcomes and should be used judiciously to minimize patient harm and optimize resource allocation.
Blood transfusions following aortic valve replacement (AVR) are associated with adverse outcomes such as acute kidney injury, infections, transfusion reactions, prolonged hospitalisation, and increased perioperative mortality [1–4]. While the need for blood transfusions to manage life-threatening bleeding is undeniable, blood products should be used judiciously. This approach helps minimise potential adverse effects for patients and ensures efficient allocation of this scarce and costly resource.
No takes yet. Share an insight, caveat, or question.
Herrero et al. (2026) conducted an editorial in Aortic valve replacement. Blood transfusion was evaluated. Blood transfusions following aortic valve replacement are associated with adverse outcomes, highlighting the need for judicious use to minimize patient harm and ensure efficient resource allocation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: